Safety and Efficacy Study of Bimatoprost in Japanese Patients With Eyelash Hypotrichosis

Eyelash Hypotrichosis Clinical Trial

Official title:
A Multicenter, Double-masked, Randomized, Parallel-group Study Assessing the Safety and Efficacy of Once-Daily Application of Bimatoprost Solution 0.03% Compared to Vehicle in Increasing Overall Eyelash Prominence in Japanese Subjects With Hypotrichosis of the Eyelashes

Status Completed

Clinical Trial Summary

This study will evaluate the safety and efficacy of bimatoprost solution 0.03% compared with vehicle in Japanese adults with hypotrichosis of the eyelashes.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT01391273
Study type	Interventional
Source	Allergan
Contact
Status	Completed
Phase	Phase 3
Start date	July 1, 2011
Completion date	May 19, 2012

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT01229423` - Safety and Efficacy of LATISSE® in the Augmentation of Eyelashes of Korean Subjects	Phase 4
Completed	`NCT01623479` - An Observational Study of Patients Treated With Bimatoprost 0.03% (Latisse®) for Hypotrichosis of the Eyelashes
Completed	`NCT01064882` - Safety and Efficacy of Bimatoprost Ophthalmic Solution in Increasing Eyelash Prominence	Phase 2
Completed	`NCT01023841` - Safety and Efficacy of Bimatoprost Solution in Treating Eyelash Loss or Hypotrichosis in Children	Phase 4
Completed	`NCT01391286` - Safety and Efficacy Study of Bimatoprost in Japanese Patients With Chemotherapy-Induced Eyelash Hypotrichosis	Phase 3
Completed	`NCT02505776` - Safety and Patient Satisfaction With GLASH VISTA™ (Bimatoprost 0.03%) in the Treatment of Eyelash Hypotrichosis in Japan